К содержанию
Dr. Tara EinullaevaMedical oncologist

Second opinion 10 min

Tumor Board: How Cancer Treatment Decisions Are Made

Who sits on a tumor board, which documents it needs, what goes into the meeting record, whether you can attend and what to do if you disagree with the decision.

Written and medically reviewed by

Dr. Tara Einullaeva

Medical oncologist, 9 years in practice. Credentials · reviewed 16 October 2026

A tumor board (also called a multidisciplinary team meeting, or MDT) is a meeting of several doctors from different specialties who look at your documents together and decide how treatment should begin: surgery, drug treatment, radiotherapy or a combination. In Russia, where these meetings are called oncology consiliums, this is not a formality: by law, the treatment approach for cancer patients is set by the board, and a board meeting is mandatory whenever the treatment method changes. Rules in other countries differ, but the principle is the same.

Below I explain how a tumor board works, what it needs from you, what the record says and what to do if the decision raises questions.

What a tumor board is and why one doctor doesn’t decide alone

Cancer is almost always treated by several specialists. The surgeon assesses whether the tumour can be removed. The medical oncologist decides whether drug treatment is needed before or after surgery. The radiation oncologist considers whether radiotherapy will help. When each of them decides separately, it’s easy to miss an option that only becomes visible when everyone looks together.

In Russian law this is set out as follows. Article 48 of Federal Law No. 323-FZ defines a consilium as a meeting of several doctors of one or more specialties. It is convened by the treating doctor — in their own hospital or outside it, including remotely. The national Procedure for Providing Medical Care for Cancer (Russian Ministry of Health Order No. 116n) adds for oncology: the treatment approach is set by the board, and when the treatment method changes, a tumor board is mandatory.

In practice this means the board meets before treatment starts and again when the plan changes — for example, if after surgery the question of drug treatment comes up, or if the disease progresses and a different kind of treatment is needed.

A 2020 review that pooled five systematic reviews showed that after discussion at such a meeting, the treatment plan changed for a noticeable proportion of patients, although the share varied widely between studies. Data on the effect on survival are still inconsistent, but the benefit for the quality of decisions looks convincing.

Who sits on the tumor board

Under Order No. 116n, a tumor board includes oncologists and a radiation oncologist, plus a neurosurgeon for tumours of the nervous system. Other specialists are invited when needed.

Specialist What they assess
Surgical oncologist Whether the tumour can be removed and how radically
Medical oncologist Whether drug treatment is needed: chemotherapy, targeted therapy, immunotherapy
Radiation oncologist Whether radiotherapy has a role, and when
Neurosurgeon Tumours of the brain and spinal cord
Other doctors as needed Radiologist, pathologist, cardiologist, etc. — if the scans, the pathology or how well you’ll tolerate treatment can’t be assessed without them

In cancer centres abroad, the MDT usually also includes a radiologist, a pathologist and a specialist nurse. In Russia their participation depends on the hospital, but the board takes their reports into account in any case.

A tumor board can be held using telemedicine. This is convenient when the view of a national centre is needed: for some diagnoses, the Procedure explicitly recommends a consultation or board meeting at a national medical research centre.

Which documents the tumor board needs

The board decides on the basis of documents. The more complete they are, the less likely the discussion is to be postponed with the words “further tests needed”.

  1. The pathology report — from the biopsy and from surgery, if you had it. This is the foundation: without a diagnosis confirmed under the microscope, it’s too early to plan treatment. I explain how to read the report in my article “How to read a pathology report”.
  2. IHC (immunohistochemistry — staining that clarifies the type of tumour and its markers) and molecular genetic tests, if your diagnosis calls for them.
  3. CT, MRI, PET-CT — reports and discs. A report is one radiologist’s opinion. The disc lets the doctors look at the images again, and board members often do.
  4. Discharge summaries from hospitals and operation notes.
  5. Blood tests — full blood count, biochemistry, tumour markers if they were measured.
  6. Other conditions and medicines: blood pressure, diabetes, heart, kidneys. These determine which treatment you will be able to tolerate.

If you have come from another city or hospital, bring the original slides and blocks — they may need to be reviewed.

What the tumor board record says

The board’s decision is recorded in a written record, signed by the participants and added to your medical records. The recommended template (Appendix No. 1 to Order No. 116n) contains:

  • the date and format of the meeting — in person or in absentia, with or without telemedicine;
  • the board members — their positions and names;
  • the diagnosis with its ICD-10 code and the TNM stage (what the letters and numbers mean is explained in my article “TNM cancer staging”);
  • the reason for the meeting, the course of the disease and the patient’s condition at the time of discussion;
  • the board’s decision;
  • a dissenting opinion, if a member disagrees with the majority.

The “dissenting opinion” line is one of the most important parts of the record. If it is filled in, the doctors were not unanimous. That is a reason to ask what the disagreement is about and, possibly, to get a second opinion.

It’s worth asking for a copy of the record. Under part 5 of Article 22 of the same Russian law, patients have the right to request their medical records, copies of them and summaries; check the rules where you are being treated.

Can the patient attend?

Order No. 116n does not require the patient to be invited. In many hospitals the board discusses the case from the documents, and the treating doctor explains the decision afterwards. Sometimes the patient is invited — to be examined, to clarify symptoms or to discuss a choice between options.

If you are invited, I suggest:

  • writing down your questions and your most important symptoms in advance (pain, weight loss, breathlessness, weakness);
  • bringing someone close to you who can take notes — under stress, a lot gets forgotten;
  • checking when and from whom you will receive the record.

If you weren’t invited, that doesn’t mean your view isn’t taken into account. After the board meeting, your treating doctor should explain the decision and the options. The final consent to treatment is yours.

What to do if you disagree with the decision

Disagreement is a normal situation, especially when it comes to disfiguring surgery or a decision to stop treatment. I would approach it in this order:

  1. Ask for the reasoning. Which clinical guidelines the board relied on, which options it considered and why it rejected them. Often the doubts go away after this conversation.
  2. Check that all the data were taken into account. That no scans were lost, that IHC and molecular tests were done, that the slides were reviewed.
  3. Get a second opinion. At another hospital or through a telemedicine consultation with a national centre. I explain how to do this without losing time in my article “Second opinion from an oncologist”.
  4. Don’t delay treatment for long. Ask your treating doctor how much time you have to think, and stay within it.

You have the right to refuse a proposed intervention, but that decision is best made once you understand all the options and their consequences.

How an online consultation complements the tumor board

An online consultation doesn’t replace the tumor board and can’t change its decision: treatment is prescribed by your treating doctor on the basis of the record. But it is useful before and after the meeting.

Before the board meeting, I help check that everything has been gathered: whether there are gaps in the pathology, whether molecular tests are needed, whether the discs are there. After the meeting, I help you understand what the record says, what other options exist under clinical guidelines and which questions to ask your doctor.

The consultation takes place on Zoom and lasts about 60 minutes; afterwards you receive a written summary. If you want to understand the tumor board’s decision or have doubts about it, I’ll go through your documents in a second-opinion consultation.

Questions to ask after the tumor board

  • What decision was made, and why was this option chosen?
  • Which alternatives were discussed, and why were they rejected?
  • Did any of the members give a dissenting opinion?
  • Have all the necessary tests been done, or could the decision change after new results?
  • When is treatment planned to start, and when will the next board meeting be?
  • Can I have a copy of the record?

A tumor board is a way to make sure your case is seen by the surgeon, the medical oncologist and the radiation oncologist at the same time. Your job is to give them complete documents and to understand the decision before you agree to it.

Sources

  1. Статья 48 Федерального закона № 323-ФЗ «Об основах охраны здоровья граждан в Российской Федерации». Врачебная комиссия и консилиум врачей (Article 48 of Federal Law No. 323-FZ “On the Fundamentals of Protecting the Health of Citizens in the Russian Federation”: Medical Commission and Consilium of Doctors) — ConsultantPlus, current version
  2. Приказ Минздрава России от 19.02.2021 № 116н «Об утверждении Порядка оказания медицинской помощи взрослому населению при онкологических заболеваниях» (Russian Ministry of Health Order No. 116n of 19 February 2021 “On Approval of the Procedure for Providing Medical Care to Adults with Cancer”) — ConsultantPlus, as amended on 3 June 2026
  3. Приложение № 1. Протокол консилиума врачей (онкологического). Рекомендуемый образец (Appendix No. 1: Record of an Oncology Consilium, Recommended Template) — ConsultantPlus, to Russian Ministry of Health Order No. 116n
  4. Письмо Минздрава России о праве пациента на медицинские документы (ч. 5 ст. 22 Федерального закона № 323-ФЗ) (Letter of the Russian Ministry of Health on the patient’s right to medical records, part 5 of Article 22 of Federal Law No. 323-FZ) — Russian Ministry of Health
  5. The impact of tumor board on cancer care: evidence from an umbrella review — BMC Health Services Research, 2020
  6. Your multidisciplinary team (MDT) — King's College Hospital NHS Foundation Trust

Frequently asked questions

This article is for information only and does not replace a consultation with your treating doctor. Decisions about tests and treatment are made by the doctor who looks after you.